相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
Stefanie Goellner et al.
NATURE MEDICINE (2017)
EZH2-mediated α-actin methylation needs lncRNA TUG1, and promotes the cortex cytoskeleton formation in VSMCs
Rong Chen et al.
GENE (2017)
Interactions of cisplatin and the copper transporter CTR1 in human colon cancer cells
Mia C. Akerfeldt et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2017)
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
Man Xiao et al.
JOURNAL OF OVARIAN RESEARCH (2017)
Comparison of different sample preparation methods for platinum determination in cultured cells by graphite furnace atomic absorption spectrometry
Man Xiao et al.
PEERJ (2017)
EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion
Xiaoqing Yi et al.
SCIENTIFIC REPORTS (2017)
EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
Horacio Cardenas et al.
ONCOTARGET (2016)
Platinum Concentration and Pathologic Response to Cisplatin-Based Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
Elizabeth A. Guancial et al.
PLOS ONE (2016)
Oxaliplatin for the treatment of ovarian cancer
Stefano Bogliolo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs
Justin C. Jagodinsky et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2015)
Involvement of enhancer of zeste homolog 2 in cisplatin-resistance in ovarian cancer cells by interacting with several genes
Huali Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
The methyltransferase Ezh2 controls cell adhesion and migration through direct methylation of the extranuclear regulatory protein talin
Merry Gunawan et al.
NATURE IMMUNOLOGY (2015)
Mitochondria-Localized Fluorescent BODIPY-Platinum Conjugate
Tingting Sun et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
EZH2-Induced H3K27me3 is Associated with Epigenetic Repression of the ARHI Tumor-Suppressor Gene in Ovarian Cancer
Yibing Fu et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
Xuemin Wang et al.
PLOS ONE (2015)
Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B
Francesco Tadini-Buoninsegni et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Molecular modulation of the copper and cisplatin transport function of CTR1 and its interaction with IRS-4
Cheng-Yu Tsai et al.
BIOCHEMICAL PHARMACOLOGY (2014)
EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1
Tao Li et al.
CANCER BIOLOGY & THERAPY (2014)
Platinum Compounds for High-Resolution In Vivo Cancer Imaging
Miles A. Miller et al.
CHEMMEDCHEM (2014)
Cancer-associated fibroblasts enhance the migration ability of ovarian cancer cells by increasing EZH2 expression
Linjuan Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer
Eric S. Kim et al.
LUNG CANCER (2014)
miR-101 regulates expression of EZH2 and contributes to progression of and cisplatin resistance in epithelial ovarian cancer
Lin Liu et al.
TUMOR BIOLOGY (2014)
Systems biology of cisplatin resistance: past, present and future
L. Galluzzi et al.
CELL DEATH & DISEASE (2014)
A novel function of protein kinase B as an inducer of the mismatch repair gene hPMS2 degradation
Jinghui Jia et al.
CELLULAR SIGNALLING (2013)
Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin
J. Cai et al.
ONCOGENESIS (2013)
A Re-Evaluation of the Role of hCTR1, the Human High-Affinity Copper Transporter, in Platinum-Drug Entry into Human Cells
Kristin D. Ivy et al.
MOLECULAR PHARMACOLOGY (2013)
Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1
Chun Yang et al.
GYNECOLOGIC ONCOLOGY (2012)
The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin
Roohangiz Safaei et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy
Helen H. W. Chen et al.
LUNG CANCER (2012)
Notch1 intracellular domain increases cytoplasmic EZH2 levels during early megakaryopoiesis
A. Roy et al.
CELL DEATH & DISEASE (2012)
EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo
Jianfeng Guo et al.
CANCER SCIENCE (2011)
Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy
Yoo-Young Lee et al.
GYNECOLOGIC ONCOLOGY (2011)
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo
Sha Hu et al.
CANCER BIOLOGY & THERAPY (2010)
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Seiko Ishida et al.
CANCER CELL (2010)
Effects of the loss of Atox1 on the cellular pharmacology of cisplatin
Roohangiz Safaei et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2009)
Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells
Jochen Zisowsky et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells
AK Holzer et al.
CLINICAL CANCER RESEARCH (2004)
The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells
AK Holzer et al.
MOLECULAR PHARMACOLOGY (2004)
Molecular signature linked to acquired resistance to cisplatin in esophageal cancer cells
H Toshimitsu et al.
CANCER LETTERS (2004)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae
XJ Lin et al.
MOLECULAR PHARMACOLOGY (2002)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
